Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W J Sandborn

Showing results (51-60 of 186) with videos related to

Pageof 19
Sort By:
The American Journal of Gastroenterology|March 31, 2001
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patientsE Ricart, R Panaccione, E V Loftus, et al.
Gastroenterology|July 27, 1999
Successful management of Crohn's disease of the ileoanal pouch with infliximabE Ricart, R Panaccione, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulationsG R Lichtenstein, M A Kamm, W J Sandborn, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 11, 2001
Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with pscW A Faubion, E V Loftus, W J Sandborn, et al.
Inflammatory Bowel Diseases|May 25, 1999
Concurrent inflammatory bowel disease and myelodysplastic syndromesG C Harewood, E V Loftus, A Tefferi, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's diseaseS B Hanauer, J Panes, J-F Colombel, et al.
Inflammatory Bowel Diseases|June 1, 2001
Crohn's disease of the esophagus: clinical features and outcomesG A Decker, E V Loftus, T M Pasha, et al.
Mayo Clinic Proceedings|May 1, 1994
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity IndexW J Sandborn, W J Tremaine, K P Batts, et al.
Alimentary Pharmacology & Therapeutics|July 12, 2012
Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipientsA B Mohabbat, W J Sandborn, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2002
The effectiveness of budesonide therapy for Crohn's diseaseS V Kane, P Schoenfeld, W J Sandborn, et al.
Pageof 19

Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
The American Journal of Gastroenterology|March 31, 2001
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patientsE Ricart, R Panaccione, E V Loftus, et al.
Gastroenterology|July 27, 1999
Successful management of Crohn's disease of the ileoanal pouch with infliximabE Ricart, R Panaccione, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulationsG R Lichtenstein, M A Kamm, W J Sandborn, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 11, 2001
Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with pscW A Faubion, E V Loftus, W J Sandborn, et al.
Inflammatory Bowel Diseases|May 25, 1999
Concurrent inflammatory bowel disease and myelodysplastic syndromesG C Harewood, E V Loftus, A Tefferi, et al.
Alimentary Pharmacology & Therapeutics|May 25, 2010
Clinical trial: impact of prior infliximab therapy on the clinical response to certolizumab pegol maintenance therapy for Crohn's diseaseS B Hanauer, J Panes, J-F Colombel, et al.
Inflammatory Bowel Diseases|June 1, 2001
Crohn's disease of the esophagus: clinical features and outcomesG A Decker, E V Loftus, T M Pasha, et al.
Mayo Clinic Proceedings|May 1, 1994
Pouchitis after ileal pouch-anal anastomosis: a Pouchitis Disease Activity IndexW J Sandborn, W J Tremaine, K P Batts, et al.
Alimentary Pharmacology & Therapeutics|July 12, 2012
Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipientsA B Mohabbat, W J Sandborn, E V Loftus, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2002
The effectiveness of budesonide therapy for Crohn's diseaseS V Kane, P Schoenfeld, W J Sandborn, et al.
Pageof 19